Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The Year 2017 in Charts

156 views

Published on

My favorite charts and graphs from articles published in Pharma Marketing News - including Pharma Industry Update & Pharma Marketing Blog - in 2017.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

The Year 2017 in Charts

  1. 1. 2017. Pharma Marketing Network. All rights reserved. The Year 2017 in Charts TM
  2. 2. 2017. Pharma Marketing Network. All rights reserved. FDA Drug Approvals See Best Year Since 1996 The FDA hit 46 approvals for 2017. That’s the most in at least a decade. The tally includes NMEs (New Molecular Entities – traditional drugs) and BLAs (Biologic License Applications – these are manufactured biologics, which do not include vaccines). http://sco.lt/61T6Jd
  3. 3. 2017. Pharma Marketing Network. All rights reserved. Orphan Drug Designations by FDA
  4. 4. 2017. Pharma Marketing Network. All rights reserved. 7 Out of 10 Top Selling Drugs Have Orphan Status An investigation by Kaiser Health News that NPR published and aired in January found that many drugs with orphan status weren’t entirely new when approved. Of about 450 drugs that have won orphan approval since 1983, more than 70 were drugs first greenlighted by the FDA for mass-market uses. Those include the cholesterol blockbuster Crestor, Abilify for psychiatric disorders, and the rheumatoid arthritis drug Humira, the world’s best-selling drug. http://sco.lt/9B2uiv
  5. 5. 2017. Pharma Marketing Network. All rights reserved. Is FDA Too Slow to Approve New Drugs? President Trump claimed that the U.S. Food and Drug Administration’s approval process for medical products is “slow and burdensome” and “keeps too many advances … from reaching those in need.” Do the data in this and the previous slide dispute that? http://sco.lt/8cp2PZ
  6. 6. 2017. Pharma Marketing Network. All rights reserved. Meanwhile FDA Letters Are a Rarity
  7. 7. 2017. Pharma Marketing Network. All rights reserved. Drug Safety Events Common after FDA Approval http://sco.lt/94NCyH
  8. 8. 2017. Pharma Marketing Network. All rights reserved. US Drug Spend Growth Slows in 2016 The U.S. health system's spending on prescription drugs grew by 5.8% to $450 billion in 2016, the slowest growth rate over the last two years, according to an annual report released Thursday by the QuintilesIMS Institute. U.S. drug spend jumped 12% in 2015 to $425 billion, compared to 2014. http://sco.lt/5D91of
  9. 9. 2017. Pharma Marketing Network. All rights reserved. Big Pharma's Effective Tax Rate is Lower Than Yours! http://sco.lt/6aaB6X
  10. 10. 2017. Pharma Marketing Network. All rights reserved. Want an ROI of 2.7? Overcharge Medicaid! For years, Mylan classified EpiPen in a way that forced Medicaid to overpay for the product, according to the Centers for Medicare and Medicaid Services. The company may have over- charged taxpayers as much as $1.27 billion over 10 years, the Department of Health and Human Services’s watchdog organization said in May, 2017. http://sco.lt/9CtwsT
  11. 11. 2017. Pharma Marketing Network. All rights reserved. Pharma Exec Compensation in 2016 What a disgrace! The chairman of a generics maker in hot water with the U.S. government and American parents—Mylan’s Robert Coury—would step off the company’s employee roster and into the nonexecutive chairman’s job and reap a $97 million package with the move http://sco.lt/7dv0ID
  12. 12. 2017. Pharma Marketing Network. All rights reserved. Pharma Commercial Support of CME The pharmaceutical industry spent more on accredited continuing medical education in 2016 than it did in 2015, with spending hitting $704 million last year, up from $693 million in 2015 — a 1.5% increase. [Note: If you include advertising and exhibit income - almost all of which is paid by pharma - then the year- over-year increase is more like 2.9%.] In 2016, about one-quarter — 28% — of all CME investment came from the phama industry, according to an annual report from the Accreditation Council for Continuing Medical Education (ACCME). http://sco.lt/6r0zqL
  13. 13. 2017. Pharma Marketing Network. All rights reserved. Pharma Payments to HCPs Topped $8 Bn in 2016 All told, nearly 631,000 physicians and approximately 1,146 teaching hospitals received $8.18 billion in payments and ownership and investment interests in 2016, according to tallies compiled by the CMS. http://sco.lt/7ohZiL
  14. 14. 2017. Pharma Marketing Network. All rights reserved. Over Half of the DTC Ad Spend by the Top 10 Advertised Drugs in 2016 was Made by Pfizer http://sco.lt/5HEoTp
  15. 15. 2017. Pharma Marketing Network. All rights reserved.
  16. 16. 2017. Pharma Marketing Network. All rights reserved. Ads for “Breakthrough” Cancer Drugs Are “An Ocean of Hype,” Say Oncologists http://sco.lt/6Ru7mL
  17. 17. 2017. Pharma Marketing Network. All rights reserved. Direct-to-Consumer Advertising (DTCA) Is Effective In Increasing Inappropriate Prescribing, Say Researchers http://sco.lt/5HEoTp
  18. 18. 2017. Pharma Marketing Network. All rights reserved. Will It Be Downhill from Here for DTC Spending? According to data from Nielsen, the U.S. drug industry spent $5.6 billion on DTC ads, excluding digital ads (read “Direct-to- Consumer #Pharma Drug Ad Spending at an All-Time High”; http://sco.lt/61NlRp According to the Nielsen chart shown here, the 2016 spend may have been $5.8 billion (excluding digital but including cinema). Related: Spending in and around much- heralded digital channels was more or less flat ($515 million in 2016 versus $516 million in 2015). http://sco.lt/5IZeSn
  19. 19. 2017. Pharma Marketing Network. All rights reserved. Form 2253 Data Show Increase in Internet Drug Ads From 2011–2014 (the years during which Internet promotion submissions were separated by audience) Internet promotion was the single largest category of FDA Form 2253 submissions for both consumer and healthcare professionals.
  20. 20. 2017. Pharma Marketing Network. All rights reserved. Americans Consume More Opioids Per Person Than Any Other Country America has about 4 percent of the world’s population — but about 27 percent of the world’s drug overdose deaths. But recently, America has gotten much worse due to its massive opioid epidemic. In 1999, fewer than 17,000 people died from drug overdoses. In 2015, that grew to more than 52,000. This is, for now, largely an American problem. After pharmaceutical companies heavily marketed their opioids in the US, and doctors followed through with massive numbers of prescriptions, America became the world’s leader in consuming opioids. http://sco.lt/6G3xbd
  21. 21. 2017. Pharma Marketing Network. All rights reserved. Wishing You a Happy New Year!

×